Colin Scott

Company: Highland Airs Consultancy

Job title: CEO

Seminars:

Exploring the Successes and Failures of Inhaled Surfactant in the Utility of Current Surfactant Aerosol Delivery Systems 3:30 pm

With the exception of FDA approvals for surfactant delivery for pre-term infants and neonates, this therapeutic modality has not delivered consistent results in the management of surfactant deficiency conditions Addressing barriers: what has hindered the addition of surfactant delivery to the therapeutic armamentarium? Enhancing aerosol delivery: what enhancements are needed to make surfactant a valuable…Read more

day: Day 2